Anthem Biosciences Financial Results
- Market cap
- ₹49,765 crore
- P/E
- 86.4
- P/B
- 16.36
- ROE
- 21.7%
- Dividend yield
- 0.23%
For the year ended Mar 2023, Anthem Biosciences reported revenue of ₹1,057 crore and net profit of ₹385 crore, against ₹1,419 crore and ₹367 crore a year earlier.
Anthem Biosciences annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | 1,057 | 1,419 | 1,845 | 2,124 | 2,002 |
| Expenses | 622 | 913 | 1,163 | 1,285 | 1,209 |
| Operating profit | 435 | 506 | 682 | 839 | 793 |
| Operating margin % | 41% | 36% | 37% | 40% | 40% |
| Other income | 134 | 62 | 75 | 126 | 133 |
| Interest | 8 | 9 | 10 | 7 | 6 |
| Depreciation | 64 | 82 | 89 | 134 | 138 |
| Profit before tax | 497 | 477 | 657 | 824 | 783 |
| Tax % | 23% | 23% | 31% | 28% | 26% |
| Net profit | 385 | 367 | 451 | 592 | 576 |
| EPS (₹) | 6.86 | 6.54 | 8.04 | 10.54 | 10.25 |
| Dividend payout % | — | — | — | — | — |
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Anthem Biosciences financial results — frequently asked questions
What is Anthem Biosciences' annual revenue and net profit?
For the financial year ended Mar 2023, Anthem Biosciences' revenue was ₹1,057 crore and net profit ₹385 crore; net profit rose 4.90% from ₹367 crore in Mar 2024.
How fast has Anthem Biosciences grown over three years?
From Mar 2026 to Mar 2023, Anthem Biosciences' revenue grew at a compound annual rate of -20.8% and net profit at -13.4%. Past growth does not indicate future results.
What is the EPS of Anthem Biosciences?
Annual EPS for Mar 2023 was ₹6.86.
Are these figures consolidated or standalone?
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade Anthem Biosciences With ATS
Track ANTHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.